Table 1.
Reanalysis of data
| Ibrutinib dose | ORR (%) | CR (%) | DLT (%) |
|---|---|---|---|
| 280 | 8/10 (80) | 5/10 (50) | 0/10 (0) |
| 420 | 18/20 (90) | 8/19 (42) | 3/21 (14) |
Data are from Table 1 of Portell et al.10
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.